What’s Next in PAT: Leveraging In Line Analytics as the Viewing Eye to Your mRNA Production for Manufacturing Control
- How have in-line analytics evolved beyond traditional immunoassays to enable continuous and precise monitoring of mRNA quality in real time
- How does QbDD (Quality by Digital Design) integration with in-line analytics enable end-to-end process simulation, improving efficiency and minimizing trial-and-error in mRNA manufacturing
- Embedding real-time analytics into GMP workflows to support adaptive control and faster decision-making? regulatory transitions
NOVEL MRNA MODALITY